---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-26-000006"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2026-01-22T23:59:59+00:00"
generated_at: "2026-05-16T08:39:36.961479+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Q4 revenue $2.87B (+19% YoY); non-GAAP EPS $2.53 vs $2.21; 2026 procedure growth guidance 13-15%

## Summary
- Q4 revenue $2.87B (+19% YoY); GAAP net income $795M ($2.21 diluted EPS); non-GAAP net income $914M ($2.53 diluted EPS).
- Worldwide da Vinci procedures +17%, Ion procedures +44% YoY; placed 532 da Vinci systems (303 da Vinci 5) and 42 Ion systems.
- Installed base: 11,106 da Vinci systems (+12% YoY); 995 Ion systems (+24% YoY).
- 2026 outlook: da Vinci procedure growth 13-15%; non-GAAP gross margin 67-68% (includes ~1.2% tariff headwind).
- Q4 included $70M contribution to Intuitive Foundation (vs $45M in Q4 2024).

## SEC filing metadata
- accession: 0001035267-26-000006
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2026-01-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000006/0001035267-26-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000006/isrg-20260122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-26-000006
- JSON: https://secwatch.observer/filing/0001035267-26-000006.json
- Plain text: https://secwatch.observer/filing/0001035267-26-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.